These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
2 files

Fe-N-C Nanozyme with Both Accelerated and Inhibited Biocatalytic Activities Capable of Accessing Drug-Drug Interaction

submitted on 22.02.2020, 15:13 and posted on 24.02.2020, 13:26 by Yuan Xu, Jing Xue, Qing Zhou, Yongjun ZHENG, Xinghua Chen, Songqin Liu, Yanfei Shen, Yuanjian Zhang

Emerged as a cost-effective and robust enzyme mimic, nanozymes have drawn increasing attention with broad applications ranging from cancer therapy to biosensing. Developing nanozymes with both accelerated and inhibited biocatalytic properties in a biological context is highly envisioned for perusing more advanced functions of natural enzymes, such as in drug-drug interaction, but remains challenging. By re-visiting the well-known Fe-N-C electrocatalyst that has a heme-like Fe-Nx coordination active center, herein, we report that the Fe-N-C with a minimum graphitization had an even superior cytochrome P450 (CYP)-like biocatalytic activity. Moreover, the drug metabolization by the Fe-N-C upon co-existence of other foods and drugs demonstrated a trend of inhibition similar to CYP, indicating its great potential as a replacement for drug dosing guide and outcome prediction. Beyond boosting the enzyme-like activity, this work would open a new vista of nanozymes with inhibited behavior for keeping up more demanding applications, enabled by further mimicking the molecular structure of enzymes.


Email Address of Submitting Author


Southeast University



ORCID For Submitting Author


Declaration of Conflict of Interest

No Conflict of Interest